Catalent is apparently eyeing more growth at its Bloomington, Indiana, campus, with news the New Jersey-based CDMO recently bought more land in the area for $1.2 million.
Arrowhead Pharmaceuticals, which focuses on genetic-based drugs for hard-to-treat diseases, is planning to spend $250 million to build a manufacturing campus in the Madison, Wisconsin, area.
Moderna is eyeing sites in Africa where it plans to build a $500 million mRNA manufacturing facility that will be able to produce hundreds of millions of doses a year in anticipation of future vaccine demand in the wake of the COVID-19 pandemic.
Cambrex plans to spend $30 million to expand small batch manufacturing capacity at its High Point, North Carolina, facility as the New Jersey-based CDMO continues the march in the U.S. to assure “onshore” production of key pharmaceuticals.
Freshpet, Inc. Releases Inaugural Environmental, Social, and Governance (ESG) Sustainability Report streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.